Plasma Prolidase Activity and Oxidative Stress in Patients with Parkinson’s Disease

Table 3

Representation of PPA, TOS, TAS, and OSI in different age groups of cases and controls.

Parameters	Cases ( = 240)			Sig. value	Controls ( = 150)			Sig. value
	<50 years (Gp1); ( = 38)	50–59 years (Gp2); ( = 85)	≥60 years; (Gp3); ( = 117)		<50 years; (Gp1); ( = 24)	50–59 years; (Gp2); ( = 51)	≥60 years; (Gp3); ( = 75)
PPA; mmol min^−1 L^−1	28.06 ± 34.29	42.91 ± 25.54	37.12 ± 29.86		61.71 ± 14.68	55.51 ± 13.57	63.87 ± 18.55
TOS; mol H2O2 Eq/L	13.30 ± 3.02	16.31 ± 2.79	17.26 ± 3.91		12.57 ± 2.60	11.54 ± 2.82	13.04 ± 2.48
TAS; mmol Trolox Eq/L	2.28 ± 0.21	1.72 ± 0.46	1.60 ± 0.47		1.93 ± 0.39	2.01 ± 0.43	1.89 ± 0.41
OSI; Arbitrary unit	5.91 ± 1.87	10.47 ± 3.92	12.40 ± 6.38		7.05 ± 2.90	6.27 ± 3.18	7.54 ± 3.35

Gp = group, = numbers of subject, = values according to one-way ANOVA, and = values according to Kruskal Wallis test.